Chest pain is among the leading patient complaints in the emergency department and ambulance services. Historically, routine oxygen supplementation was recommended in all patients with symptoms suggestive of AMI, owing to its "low risk of harm" and potential benefits. In particular, ambulance services have a long history of delivering high concentration oxygen therapy to patients irrespective of peripheral oxygen saturation . The cost of providing a treatment with little clinical value is now in question.
I wonder if one of the authors could comment on the cost of providing oxygen therapy in the context of the DETO2X protocol? Indeed this trial has enormous efficiency benefits if translated into practice, so I'd be very interested to hear what the cost implications would be if we withheld routine oxygen supplementation in this large population of patients?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.